Key facts
- It has raised $200K; the latest was Seed Round ($200K) in Feb 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for EndoUVtech
- ·The full record, as it builds
Funding rounds
No funding rounds for EndoUVtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EndoUVtech
Operator of a medical device company intended to improve the treatment of ischemic strokes during endovascular brain procedures. The company leverages ultraviolet laser-based technology to work in conjunction with standard mechanical thrombectomy procedures, using a catheter to gently widen blood vessels and help break down or clear smaller clots, enabling the healthcare industry to improve patient recovery and long-term neurological outcomes.
- Sector
- Healthcare
- HQ
- Oakland Park, FL, United States
- Founded
- 1991
- Employees
- 5
- Website
- endouvtech.com/
- Ownership
- Privately Held (backing)
EndoUVtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EndoUVtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EndoUVtech in its N-PORT filings yet. We sweep new filings monthly.